What's new

Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 11, Status: Authorised

Apr 28, 2025 - 14:54
 0
Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

USA meetings industry trends: Regional update for Q1 2025

Next Article

Human medicines European public assessment report (EPAR): LysaKare, arginine,lys...

Related Posts

Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0

Vaccine-preventable diseases: key facts

Vaccine-preventable diseases: key facts

Apr 28, 2025  0

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0